Drugs / Glubran®2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06756074 | Jan 2025 → Apr 2026 overdue | pancreatic ductal adenocarcinoma | Minia University | Recruiting | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glubran2 | “This randomized controlled trial evaluated the efficacy of reinforcing the pancreaticojejunostomy (PJ) with Glubran®2, a modified N-butyl-2-cyanoacrylate adhesive, in reducing...” PMID 42381068 ↗ Jun 2026 |